Literature DB >> 2255337

An approach to differentiate between noradrenaline-elicited contractile processes in the rat isolated aorta.

P Koch1, B Wilffert, D Wilhelm, T Peters.   

Abstract

The aim of the present study was to assess the different processes contributing to the contraction induced by noradrenaline (NA, 1 mumol/l) in the rat isolated aorta. Pretreatment with maximally effective concentrations of nifedipine or cromakalim reduced the NA-induced contraction to 80 +/- 3.5% or 63 +/- 2.0%, respectively, without alteration of the shape of the response. After pretreatment with Mn2+, NA caused a transient phasic contraction followed by a sustained tonic component, comparable to the response obtained in "Ca2(+)-free" medium. Ryanodine--in the presence of extracellular Ca2(+)-caused a slight increase in resting tension, but did not modify the NA-induced contraction. In "Ca2(+)-free" medium the contraction elicited by NA consisted of a transient phasic and a sustained tonic component. The amplitude of the phasic contraction decreased exponentially with the time of exposure to "Ca2(+)-free" medium. The phasic component was identified as elicited by Ca2+ released from the sarcoplasmic reticulum (SR) by means of ryanodine. If Ca2+ depleted tissues (80 min in "Ca2(+)-free" solution) were exposed to Ca2+ in the presence of Mn2+ or cromakalim, the NA-induced phasic response was inhibited, suggesting that Mn2+ and cromakalim blocked the refilling of the store. It can be concluded that activation of alpha 1-adrenoceptors in the rat aorta by NA elicits Ca2(+)-entry processes which have a different sensitivity to nifedipine, cromakalim and Mn2+. The Ca2+ released from SR contributes about 20% to the overall contractile response. Our data suggest that the depleted SR can be refilled from the extracellular space via a direct cromakalim- and Mn2(+)-sensitive pathway.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2255337     DOI: 10.1007/bf00169464

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  42 in total

Review 1.  Receptor-mediated Ca2+ entry: diversity of function and mechanism.

Authors:  T J Hallam; T J Rink
Journal:  Trends Pharmacol Sci       Date:  1989-01       Impact factor: 14.819

Review 2.  Calcium release in smooth muscle.

Authors:  H Karaki; G B Weiss
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

Review 3.  The pharmacology of ryanodine.

Authors:  D J Jenden; A S Fairhurst
Journal:  Pharmacol Rev       Date:  1969-03       Impact factor: 25.468

Review 4.  Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.

Authors:  K P Minneman
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

5.  TPA-induced contraction of isolated rabbit vascular smooth muscle.

Authors:  H Rasmussen; J Forder; I Kojima; A Scriabine
Journal:  Biochem Biophys Res Commun       Date:  1984-07-31       Impact factor: 3.575

6.  Induction of Ca++ influx and intracellular Ca++ release in isolated rat aorta and mesenteric resistance vessels by norepinephrine activation of alpha-1 receptors.

Authors:  C Cauvin; S Malik
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

7.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

Authors:  H Hidaka; M Inagaki; S Kawamoto; Y Sasaki
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

8.  Regulation of cytosolic free calcium in fura-2-loaded rat parotid acinar cells.

Authors:  J E Merritt; T J Rink
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

9.  Sarcoplasmic reticulum and excitation-contraction coupling in mammalian smooth muscles.

Authors:  C E Devine; A V Somlyo; A P Somlyo
Journal:  J Cell Biol       Date:  1972-03       Impact factor: 10.539

10.  Ryanodine modification of cardiac muscle responses to potassium-free solutions. Evidence for inhibition of sarcoplasmic reticulum calcium release.

Authors:  J L Sutko; J L Kenyon
Journal:  J Gen Physiol       Date:  1983-09       Impact factor: 4.086

View more
  1 in total

1.  Study of the in vivo and in vitro cardiovascular effects of (+)-glaucine and N-carbethoxysecoglaucine in rats.

Authors:  F Orallo; A Fernández Alzueta; M Campos-Toimil; J M Calleja
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.